Rational therapy of myasthenia gravis

J. C. Finley, R. M. Pascuzzi

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Once the diagnosis of autoimmune myasthenia gravis (MG) has been established, the clinician must develop an appropriate management plan. This review summarizes the available data regarding the natural course of the disease and the effect of the five commonly used therapies: cholinesterase inhibitors (CEIs), thymectomy, corticosteroids, nonsteroidal immunosuppressive drugs, and plasma exchange (PE). These data provide the basis for general guidelines of long-term management. All current therapies have limitations and drawbacks; therefore strategies for potential future therapy are addressed.

Original languageEnglish (US)
Pages (from-to)70-82
Number of pages13
JournalSeminars in Neurology
Volume10
Issue number1
DOIs
StatePublished - Jan 1 1990

Fingerprint

Myasthenia Gravis
Thymectomy
Plasma Exchange
Cholinesterase Inhibitors
Immunosuppressive Agents
Adrenal Cortex Hormones
Therapeutics
Guidelines
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Rational therapy of myasthenia gravis. / Finley, J. C.; Pascuzzi, R. M.

In: Seminars in Neurology, Vol. 10, No. 1, 01.01.1990, p. 70-82.

Research output: Contribution to journalReview article

Finley, J. C. ; Pascuzzi, R. M. / Rational therapy of myasthenia gravis. In: Seminars in Neurology. 1990 ; Vol. 10, No. 1. pp. 70-82.
@article{a963ef0f7fb04eef8b670222fd8be153,
title = "Rational therapy of myasthenia gravis",
abstract = "Once the diagnosis of autoimmune myasthenia gravis (MG) has been established, the clinician must develop an appropriate management plan. This review summarizes the available data regarding the natural course of the disease and the effect of the five commonly used therapies: cholinesterase inhibitors (CEIs), thymectomy, corticosteroids, nonsteroidal immunosuppressive drugs, and plasma exchange (PE). These data provide the basis for general guidelines of long-term management. All current therapies have limitations and drawbacks; therefore strategies for potential future therapy are addressed.",
author = "Finley, {J. C.} and Pascuzzi, {R. M.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1055/s-2008-1041256",
language = "English (US)",
volume = "10",
pages = "70--82",
journal = "Seminars in Neurology",
issn = "0271-8235",
publisher = "Thieme Medical Publishers",
number = "1",

}

TY - JOUR

T1 - Rational therapy of myasthenia gravis

AU - Finley, J. C.

AU - Pascuzzi, R. M.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Once the diagnosis of autoimmune myasthenia gravis (MG) has been established, the clinician must develop an appropriate management plan. This review summarizes the available data regarding the natural course of the disease and the effect of the five commonly used therapies: cholinesterase inhibitors (CEIs), thymectomy, corticosteroids, nonsteroidal immunosuppressive drugs, and plasma exchange (PE). These data provide the basis for general guidelines of long-term management. All current therapies have limitations and drawbacks; therefore strategies for potential future therapy are addressed.

AB - Once the diagnosis of autoimmune myasthenia gravis (MG) has been established, the clinician must develop an appropriate management plan. This review summarizes the available data regarding the natural course of the disease and the effect of the five commonly used therapies: cholinesterase inhibitors (CEIs), thymectomy, corticosteroids, nonsteroidal immunosuppressive drugs, and plasma exchange (PE). These data provide the basis for general guidelines of long-term management. All current therapies have limitations and drawbacks; therefore strategies for potential future therapy are addressed.

UR - http://www.scopus.com/inward/record.url?scp=0025184384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025184384&partnerID=8YFLogxK

U2 - 10.1055/s-2008-1041256

DO - 10.1055/s-2008-1041256

M3 - Review article

C2 - 2189183

AN - SCOPUS:0025184384

VL - 10

SP - 70

EP - 82

JO - Seminars in Neurology

JF - Seminars in Neurology

SN - 0271-8235

IS - 1

ER -